or Try an Advanced Search...

    Technical Analysis for ITOS - iTeos Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 7.85 -0.63% -0.05
    ITOS closed down 0.63 percent on Wednesday, November 20, 2024, on 66 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ITOS trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    180 Bearish Setup Bearish Swing Setup 0.00%
    Slingshot Bearish Bearish Swing Setup 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    MACD Bearish Signal Line Cross Bearish -0.63%
    NR7 Range Contraction -0.63%
    Narrow Range Bar Range Contraction -0.63%
    Lower Bollinger Band Walk Weakness -0.63%
    New 52 Week Low Weakness -0.63%
    Older End-of-Day Signals for ITOS ...

       Recent Intraday Alerts

    Alert Time
    Up 5% about 21 hours ago
    Up 3% about 21 hours ago
    Up 2% about 21 hours ago
    60 Minute Opening Range Breakout about 22 hours ago
    Down 1% about 22 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ITOS Chart by TradingView
    Basic chart:

    Profile

    Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for cancer patients. Its product pipeline includes EOS-850, a small molecule antagonist of the adenosine A2a receptor; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains. The company was founded in 2011 and is based in Cambridge, Massachusetts with an additional location in Gosselies, Belgium.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Adenosine Therapeutics For Cancer

    Is ITOS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 iTeos Therapeutics, Inc. (NASDAQ:ITOS) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
    Nov 12 iTeos Therapeutics GAAP EPS of -$1.05 beats by $0.12
    Nov 12 iTeos Reports Third Quarter 2024 Financial Results and Provides Business Updates
    Oct 24 iTeos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 A2A-005 Clinical Trial Data in 2L NSCLC at ESMO Immuno-Oncology Congress
    Sep 16 Nuvalent Flies On 'Multibillion-Dollar' Potential, While Iteos Crashes On Patient Deaths
    Sep 16 Crude Oil Surges Over 1%; Instil Bio Shares Plunge
    Sep 16 Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket
    Sep 16 ESMO 2024: TIGIT race tightens with first look at GSK/iTeos’s TIGIT in NSCLC
    Sep 15 iTeos Therapeutics: ESMO Data Showing Signs Of A Real Win For TIGIT
    Sep 14 TIGIT drug from iTeos shrinks lung tumors in trial
    See more ITOS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 18.75
    52 Week Low 7.66
    Average Volume 761,063
    200-Day Moving Average 13.06
    50-Day Moving Average 9.79
    20-Day Moving Average 8.72
    10-Day Moving Average 8.62
    Average True Range 0.53
    RSI (14) 29.58
    ADX 22.49
    +DI 18.86
    -DI 26.54
    Chandelier Exit (Long, 3 ATRs) 8.11
    Chandelier Exit (Short, 3 ATRs) 9.26
    Upper Bollinger Bands 9.68
    Lower Bollinger Band 7.76
    Percent B (%b) 0.04
    BandWidth 21.95
    MACD Line -0.52
    MACD Signal Line -0.49
    MACD Histogram -0.0314
    Fundamentals Value
    Market Cap 280.91 Million
    Num Shares 35.8 Million
    EPS -1.75
    Price-to-Earnings (P/E) Ratio -4.49
    Price-to-Sales 5.87
    Price-to-Book 0.64
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 8.69
    Resistance 3 (R3) 8.77 8.58 8.55
    Resistance 2 (R2) 8.58 8.36 8.54 8.50
    Resistance 1 (R1) 8.21 8.23 8.12 8.13 8.46
    Pivot Point 8.02 8.02 7.97 7.98 8.02
    Support 1 (S1) 7.65 7.80 7.56 7.57 7.24
    Support 2 (S2) 7.46 7.67 7.42 7.20
    Support 3 (S3) 7.09 7.46 7.15
    Support 4 (S4) 7.01